LYMPHOMA, T-CELL

Clinical trials for LYMPHOMA, T-CELL explained in plain language.

Never miss a new study

Get alerted when new LYMPHOMA, T-CELL trials appear

Sign up with your email to follow new studies for LYMPHOMA, T-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

Smarter dosing may cut chemo side effects in lymphoma transplant

Symptom relief Ongoing

This study tests a new way to calculate the dose of the chemotherapy drug melphalan for people with lymphoma who are about to have a stem cell transplant. Instead of using a standard dose based on height and weight, researchers use a model that considers how previous patients pro…

Matched conditions: LYMPHOMA, T-CELL

Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief

Last updated Apr 30, 2026 15:49 UTC

LYMPHOMA, T-CELL

Get alerted when new LYMPHOMA, T-CELL trials appear

Smarter dosing may cut chemo side effects in lymphoma transplant